Clinical Trial: A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07344584) titled 'A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for Correction of Lines and Wrinkles in the Cheek Area' on Jan. 07.

Brief Summary: The primary objective of the study is to evaluate the safety of GP0122 and GP0124 for the correction of lines and wrinkles in the cheek area.

Study Start Date: Jan. 16

Study Type: INTERVENTIONAL

Condition: Wrinkle Reduction

Intervention: DEVICE: GP0122

Injectable gel.

DEVICE: GP0124

Injectable gel.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Galderma R&D

Disclaimer: Curated by HT Syndication....